Plumline Life Sciences Participated in
the Animal Health Innovation Asia Conference Hong Kong 2018.
Marketing Discussion with Global Animal Health Companies
after the Showcase Presentation
Plumbline Animal DNA medicines aims to unlock the full potential of global animal medicine by delivering a new class of nucleic acid-based DNA animal medicine.
DNA medicine is highly potent and safe, like mRNA medicine, and it will remain stable at room temperature for more than a year. Also, the manufacturing process of DNA plasmid is relatively simple, as it does not require the encapsulation process.
Plumbline is applying this DNA medicine platform technology to develop both companion animal therapeutics and farm animal vaccines.